SCHWABE STEFAN K.F.

PrivateCIK: 1557657
Location

ROCKVILLE, MD

SCHWABE STEFAN K.F. (Executive Vice President R&D) sold 95.1% of their position (53.65K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $1.17M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderSCHWABE STEFAN K.F.CIK 1557657
Officer· Executive Vice President R&D
Since Feb 2019
-53.65K
Net shares
Net seller
$1.17M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
53.65K acquired · 107.31K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+50K

Price / share

$9.13

Trade value

$456.50K

% of position

1803.8%
12/14/2020
2.77K52.77K

Common Stock

Direct
M · Option Exercise

Shares

+3.65K

Price / share

$12.98

Trade value

$47.42K

% of position

6.9%
12/14/2020
52.77K56.42K

Common Stock

Direct
S · Sale

Shares

50K

Price / share

$21.86

Trade value

$1.09M

% of position

88.6%
12/14/2020
56.42K6.42K

Common Stock

Direct
S · Sale

Shares

3.65K

Price / share

$22.00

Trade value

$80.37K

% of position

56.9%
12/14/2020
6.42K2.77K
Total

Net shares

+0.00

Net value

-$669.35K

Derivative Transactions2

Employee Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

50K shares

Shares

50K

Strike price

9.13

Held after

0.00

Exercisable

12/14/2020

Employee Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

3.65K shares

Shares

3.65K

Strike price

12.98

Held after

46.35K

Exercisable

12/14/2020
SCHWABE STEFAN K.F. — Insider Transaction (Form 4) Filed Dec 15, 2020 | Finecho